Published in Adv Exp Med Biol on January 01, 1984
Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR. J Clin Microbiol (1995) 1.57
Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J Virol (2005) 1.43
Antigenic comparison of feline coronavirus isolates: evidence for markedly different peplomer glycoproteins. J Virol (1987) 1.25
Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol (2005) 1.15
Significance of coronavirus mutants in feces and diseased tissues of cats suffering from feline infectious peritonitis. Viruses (2009) 1.13
Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronaviruses. Vet Microbiol (2008) 0.99
Competitive enzyme immunoassays for the rapid detection of antibodies to feline infectious peritonitis virus polypeptides. J Clin Microbiol (1985) 0.95
Feline lectin activity is critical for the cellular entry of feline infectious peritonitis virus. J Virol (2010) 0.86
An outbreak of feline infectious peritonitis in a Taiwanese shelter: epidemiologic and molecular evidence for horizontal transmission of a novel type II feline coronavirus. Vet Res (2013) 0.86
Emerging viruses in the Felidae: shifting paradigms. Viruses (2012) 0.85
Prevalence of Korean cats with natural feline coronavirus infections. Virol J (2011) 0.83
Feline and canine coronaviruses: common genetic and pathobiological features. Adv Virol (2011) 0.82
Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease. Antiviral Res (2012) 0.81
Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses. J Virol (2015) 0.78
Tackling feline infectious peritonitis via reverse genetics. Bioengineered (2014) 0.77
Antiviral Activity of Graphene-Silver Nanocomposites against Non-Enveloped and Enveloped Viruses. Int J Environ Res Public Health (2016) 0.75
Definition and antagonism of histamine H 2 -receptors. Nature (1972) 18.58
Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci (1983) 6.89
Metiamide--an orally active histamine H2-receptor antagonist. Agents Actions (1973) 6.82
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 6.56
Comparison of some properties of pronethalol and propranolol. Br J Pharmacol Chemother (1965) 4.71
Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc Natl Acad Sci U S A (1989) 4.57
Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res (1988) 3.89
Experimental transmission of Bartonella henselae by the cat flea. J Clin Microbiol (1996) 3.67
Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med (1995) 3.31
Genetic basis for species vulnerability in the cheetah. Science (1985) 3.16
Seroepidemiologic survey of captive Old-World primates for antibodies to human and simian retroviruses, and isolation of a lentivirus from sooty mangabeys (Cercocebus atys). Int J Cancer (1986) 3.09
Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc (1989) 2.97
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital. Antimicrob Agents Chemother (1990) 2.91
An analysis of the depressor responses to histamine in the cat and dog: involvement of both H1- and H2-receptors. Br J Pharmacol (1975) 2.91
Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers. J Clin Microbiol (1995) 2.83
An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol (1985) 2.68
Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J Virol (1991) 2.50
Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J Virol (1987) 2.49
Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol (1990) 2.40
Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay. Br J Pharmacol (1985) 2.37
The role of the lymphatic system in the rejection of homografts: a study of lymph from renal transplants. J Exp Med (1970) 2.34
RNA-binding proteins of bovine rotavirus. J Virol (1986) 2.26
Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J Virol (1993) 2.26
The isolated stomach preparation of the mouse: a physiological unit for pharmacological analysis. Br J Pharmacol (1985) 2.25
A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol (1994) 2.23
9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques. Antimicrob Agents Chemother (1996) 2.15
Feline immunodeficiency virus infection in cats of Japan. J Am Vet Med Assoc (1989) 2.13
Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay. J Clin Microbiol (1991) 2.08
Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology (1998) 2.07
Experimental and natural infection with Bartonella henselae in domestic cats. Comp Immunol Microbiol Infect Dis (1997) 1.99
Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27. J Immunol Methods (1983) 1.94
Breast disease: dynamic spiral MR imaging. Radiology (1998) 1.89
Natural variation of canine parvovirus. Science (1985) 1.89
Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J Med Primatol (1989) 1.88
Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol (1990) 1.86
An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis. Am J Vet Res (1981) 1.85
Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol (1991) 1.83
Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J Interferon Res (1986) 1.83
Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA. AIDS Res Hum Retroviruses (2001) 1.82
Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine. J Virol (1991) 1.79
Analysis of anomalous pKb values for metiamide and atropine in the isolated stomach of the mouse. Br J Pharmacol (1979) 1.78
Outbreak of fatal salmonellosis in cats following use of a high-titer modified-live panleukopenia virus vaccine. J Am Vet Med Assoc (1999) 1.75
Molecular, clinical, and pathologic comparison of two distinct strains of Haemobartonella felis in domestic cats. Am J Vet Res (1998) 1.75
Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J Acquir Immune Defic Syndr (1991) 1.75
Evolution of canine parvovirus involved loss and gain of feline host range. Virology (1996) 1.73
Antigenic relationship of the feline infectious peritonitis virus to coronaviruses of other species. Arch Virol (1978) 1.72
Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac. J Virol (1991) 1.71
Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. J Virol (1994) 1.69
Membrane localization of the pertussis toxin-sensitive G-protein subunits alpha i-2 and alpha i-3 and expression of a metallothionein-alpha i-2 fusion gene in LLC-PK1 cells. Proc Natl Acad Sci U S A (1990) 1.69
Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J Virol (1989) 1.63
Cyclic neutropenia in grey collie dogs. Blood (1967) 1.62
Interactive influence of infectious disease and genetic diversity in natural populations. Trends Ecol Evol (1988) 1.60
'Candidatus Mycoplasma haemominutum', a low-virulence epierythrocytic parasite of cats. Int J Syst Evol Microbiol (2001) 1.59
Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection. AIDS (1998) 1.58
Isolation of a previously undescribed rickettsia from an aborted bovine fetus. J Clin Microbiol (1990) 1.58
Abortion and death in pregnant bitches associated with a canine vaccine contaminated with bluetongue virus. J Am Vet Med Assoc (1994) 1.56
Production of acid secretion in the mouse isolated stomach by electrical field stimulation [proceedings]. Br J Pharmacol (1978) 1.54
Immunologic phenomena in the effusive form of feline infectious peritonitis. Am J Vet Res (1980) 1.54
Alternatives to blood as a source of DNA for large-scale scanning studies of canine genome linkages. Vet Res Commun (2003) 1.52
Effects in man of histamine H 2 -receptor blockade by burimamide. Lancet (1972) 1.51
The pharmacology of cimetidine, a new histamine H2-receptor antagonist. Br J Pharmacol (1975) 1.51
Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection. Antimicrob Agents Chemother (1992) 1.51
The global spread and replacement of canine parvovirus strains. J Gen Virol (1988) 1.50
Analysis of genetic variation in 28 dog breed populations with 100 microsatellite markers. J Hered (2003) 1.49
The pharmacological classification of practolol and chloropractolol. Mol Pharmacol (1978) 1.49
Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes. J Virol (1991) 1.49
Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. Am J Vet Res (1984) 1.48
Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach. Br J Pharmacol (1985) 1.48
Experimental abortion and the systemic immune response to "Haemophilus somnus" in cattle. Infect Immun (1986) 1.48
Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus. J Clin Microbiol (1996) 1.46
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. AIDS Res Hum Retroviruses (1998) 1.46
Detection and molecular characterization of cultivable caliciviruses from clinically normal mink and enteric caliciviruses associated with diarrhea in mink. Arch Virol (2001) 1.45
Estimation of pKB values for histamine H2-receptor antagonists using an in vitro acid secretion assay. Br J Pharmacol (1980) 1.45
Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression. AIDS (2000) 1.44
Antigenic relationships among homologous structural polypeptides of porcine, feline, and canine coronaviruses. Infect Immun (1982) 1.43
Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach. Br J Pharmacol (1985) 1.42
Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology (1992) 1.42
Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome. Antimicrob Agents Chemother (1989) 1.40
Research training for veterinarians and graduate education in veterinary medical colleges. J Am Vet Med Assoc (1993) 1.40
Noninfectious canine arthritis: the inflammatory, nonerosive arthritides. J Am Vet Med Assoc (1976) 1.39
Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques. J Virol (1995) 1.31
Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node. J Virol (1996) 1.31
RNA-binding proteins of coronavirus MHV: detection of monomeric and multimeric N protein with an RNA overlay-protein blot assay. Virology (1986) 1.30
One-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronaviruses. J Virol Methods (1999) 1.30
Development and evaluation of immunoassay for detection of antibodies to the feline T-lymphotropic lentivirus (feline immunodeficiency virus). J Clin Microbiol (1989) 1.30
Evidence for the maintenance of hematopoiesis in a large animal by the sequential activation of stem-cell clones. Proc Natl Acad Sci U S A (1990) 1.30
Detection and differentiation by sandwich enzyme-linked immunosorbent assay of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus- and acquired immunodeficiency syndrome-associated retroviruslike clinical isolates. J Clin Microbiol (1986) 1.28
Shared antigenic epitopes of the major core proteins of human and simian immunodeficiency virus isolates. J Med Primatol (1992) 1.26
Serologic studies of naturally occurring feline infectious peritonitis. Am J Vet Res (1976) 1.24
Comparison of indirect immunofluorescence and Western blot for detection of anti-human immunodeficiency virus antibodies. J Clin Microbiol (1987) 1.24
Prevention of simian acquired immune deficiency syndrome with a formalin-inactivated type D retrovirus vaccine. J Virol (1986) 1.24
Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach. Br J Pharmacol (1985) 1.23